Announcement
31 Jul 2026
In July 2026, the U.S. Administration reduced the Section 232 tariff rate on patented pharmaceutical imports from the United Kingdom from 10% to zero.
Source
Number of interventions
1
0 certainly harmful
0 likely harmful
1 liberalising
Implementation date
31 Jul 2026
Revocation date:
No revocation date
Recent update from 03 Aug 2026:
On 31 July 2026, the Bureau of Industry and Security of the U.S. Department of Commerce issued a notice reducing the Section 232 tariff rate on patented pharmaceuticals and associated pharmaceutica...
Announced: 01 Dec 2025
United States of America: U.S. Administration’s commitments under an agreement on pharmaceutical pricing with the United Kingdom
Announced: 01 Dec 2025
United Kingdom: UK Government’s commitments under an agreement on pharmaceuticals with the United States
Clarification: 30 Jul 2026
United States of America: U.S. Administration imposes Section 232 tariffs on pharmaceutical imports
See all
This Thread tracks liberalising trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
15226
187
This GTA Thread tracks all Section 232 investigations initiated by the United States since 2018 under the Trade Expansion Act of 1962. These investigations assess whether imports of certain goods threaten U.S. national security by examining domestic capacity, supply chain vulnerabilities, and import dependence. Only investigations formally announced by the U.S. Government are included.
Published: 14 Aug 2025
140
1